.png)
Predicine is a molecular insights company committed to advancing biomarker-driven precision medicine. It has developed a breakthrough cell-free DNA and cell-free RNA based liquid biopsy technology for non-invasive cancer profiling, disease monitoring, assessing MRD, and early cancer detection. Predicine partners with leading biopharma companies and hospitals to support global clinical trials and personalized cancer care.
Sanyou Biopharmaceuticals is a CRO company featuring phage display antibody libraries of trillion capacity and offering integrated solutions for innovative antibody drugs that include antibody discovery, efficacy validations and CMC. Currently, the company has 240+ employees, R&D laboratories of 11000 m2 and 300+ clients and partners all around the world.
We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry. By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.
With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
Veracyte is a pioneering, global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. Our growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. Veracyte offers customized multi-omics tools and expertise to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs.
With over 15 years of experience in genetic and epigenetic clinical research, EpigenDx offers high quality products and laboratory services focused on DNA methylation analysis, gene expression profiling, and mutation analysis. Our scientific teams carefully evaluate each project and establish analysis procedures using best fit technologies, including NGS, Pyrosequencing, RT-PCR, digital PCR, and GeneChip Microarray. Our popular services include Line-1 global methylation tests and Foxp3-TSDR analysis for epigenetic immunotherapy. Our GLP compliant and CLIA certified services make us the perfect partner during pre-clinical research and diagnostic test development.
Precision Antibody prides itself in developing application-specific antibodies with high specificity and sensitivity. In the field of biomarkers, the specificity and sensitivity of reagents are key performance characteristics for a successful assay development necessary for clinical application. With over 20 years of experience and expertise, Precision Antibody (PA) understands these challenges, offering a “one-stop shop” for many clients needing comprehensive application-specific antibody development services, from initial antigen design and immunization to antibody development, characterization, sequencing, and purification. Thanks to our ability to deliver antibodies that work in the intended assay in 60 days, PA has become a preferred vendor for many major pharmaceutical, biotech, and diagnostic companies, including many academic and government institutions, to fulfill their therapeutic and diagnostic needs.
Oncocyte is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
DetermaIO, a gene expression assay, assesses components of the Tumor Immune Micro-Environment (TIME) to determine the likelihood of benefit from Immune Checkpoint Inhibitor therapy.
Oncocyte believes in democratizing our laboratory offerings via widely distributed kits and is developing a TIME assessment kit for research use.
Explore further at www.oncocyte.com.
Established in 2004, LARVOL combines the best of artificial and human intelligence to deliver expertly curated and personalized data solutions to medical affairs, competitive intelligence, commercial, and R&D teams within the pharmaceutical and biotech industry.
Veranex is the leading end-to-end service provider for medical device companies. Through our proven expertise and resources, we help medtech leaders accelerate innovations to market. Our purpose-built, multi-disciplinary global teams pull from an unparalleled breadth and depth of experience to anticipate challenges and proactively find solutions at every stage of the development-to-commercial-launch continuum. Together, we can advance innovation to improve patient outcomes.
Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies. Biointron holds a leading position in the antibody expression service industry. From gene sequence to purified antibodies, our production only takes 2 weeks. We have delivered tens of thousands of recombinant antibodies for more than 1,500 biotech and pharma companies worldwide.
Q2 Solutions is a leading global clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. Q2 Solutions uses global experience, innovation and scientific expertise to transform science and data into medical insights that turn hope into help. A joint venture of IQVIA and Quest Diagnostics, Q2 Solutions leverages each parent organization’s clinical trials laboratory capabilities and treats each sample as if a life depends on it.
Biological Dynamics, Inc. is a leader in exosome-isolation technology committed to improving global health outcomes by identifying early-stage diseases. Its Verita™ platform offers a simple and automated workflow to enrich exosomes, powering advanced detection tests for the most challenging diseases. Biological Dynamics’ ExoVita™ assays utilize the Verita platform to enable reliable surveillance and early cancer detection to help enhance and extend lives. The Company operates a CAP-accredited, CLIA-certified clinical laboratory in San Diego, California.
Based on the fully human antibody transgenic RenMab™, RenLite™, and RenNano™ Mice, Biocytogen has integrated its technology platforms in single-cell antibody discovery, gene editing, large-scale disease mouse model supply, and in vivo pharmacology screening to form a new approach to streamline the entire antibody drug discovery and development process. Biocytogen collaborates with global partners to accelerate new drug discovery and development. For more information, please visit www.biocytogen.com
.png)
With over 15 years of expertise in gene editing and cell products, Applied StemCell (ASC) is a leading end-to-end provider known for pioneering innovations with two high-impact platforms, CRISPR/TARGATT™ Genome Editing and iPSC (GMP grade).
ASC is ready to offer services on custom mouse model generation and preclinical animal studies. We can also supply a catalog of 9,000+ ready-to-use mouse models for immediate use in gene function, drug screening, and human disease research.
Discover our range of services and how we can collaborate to create a comprehensive project plan tailored to your needs in cancer, immunotherapy, neurological or drug product studies.
Frontage Laboratories, Inc., is a global Contract Research Organization (CRO) which provides integrated, science-driven, product development services from drug discovery to late phase clinical process to enable biopharmaceutical companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions.
